Testing effectiveness (Phase 2)Study completedNCT02961374
What this trial is testing
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Who this might be right for
Attenuated Familial Adenomatous PolyposisFamilial Adenomatous Polyposis
National Cancer Institute (NCI) 46